WealthPLAN Partners LLC raised its stake in McKesson Co. (NYSE:MCK – Free Report) by 23.5% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,363 shares of the company’s stock after acquiring an additional 259 shares during the period. WealthPLAN Partners LLC’s holdings in McKesson were worth $796,000 at the end of the most recent quarter.
Other large investors also recently modified their holdings of the company. RFP Financial Group LLC lifted its position in McKesson by 9.8% during the second quarter. RFP Financial Group LLC now owns 191 shares of the company’s stock worth $112,000 after purchasing an additional 17 shares during the period. Modera Wealth Management LLC lifted its holdings in shares of McKesson by 2.2% during the 2nd quarter. Modera Wealth Management LLC now owns 804 shares of the company’s stock worth $470,000 after acquiring an additional 17 shares during the period. Larson Financial Group LLC boosted its position in shares of McKesson by 1.6% during the 2nd quarter. Larson Financial Group LLC now owns 1,094 shares of the company’s stock worth $639,000 after acquiring an additional 17 shares in the last quarter. First Western Trust Bank increased its stake in McKesson by 2.0% in the first quarter. First Western Trust Bank now owns 913 shares of the company’s stock valued at $490,000 after acquiring an additional 18 shares during the last quarter. Finally, Lindbrook Capital LLC raised its position in McKesson by 1.7% during the first quarter. Lindbrook Capital LLC now owns 1,133 shares of the company’s stock valued at $608,000 after purchasing an additional 19 shares in the last quarter. 85.07% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
MCK has been the topic of several recent analyst reports. Wells Fargo & Company decreased their price target on McKesson from $576.00 to $535.00 and set an “equal weight” rating on the stock in a research note on Friday, September 13th. Bank of America boosted their target price on McKesson from $590.00 to $670.00 and gave the stock a “buy” rating in a research note on Tuesday, June 25th. Evercore ISI dropped their target price on shares of McKesson from $660.00 to $630.00 and set an “outperform” rating for the company in a report on Thursday, August 8th. Argus lifted their price target on shares of McKesson from $570.00 to $670.00 and gave the company a “buy” rating in a report on Monday, June 24th. Finally, Robert W. Baird dropped their price objective on shares of McKesson from $694.00 to $671.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Two investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, McKesson has an average rating of “Moderate Buy” and a consensus price target of $620.93.
McKesson Trading Down 1.1 %
NYSE MCK opened at $513.91 on Wednesday. McKesson Co. has a 12 month low of $422.15 and a 12 month high of $637.51. The firm has a market capitalization of $66.64 billion, a PE ratio of 22.96, a price-to-earnings-growth ratio of 1.18 and a beta of 0.44. The business’s 50-day moving average price is $564.48 and its two-hundred day moving average price is $557.67.
McKesson (NYSE:MCK – Get Free Report) last released its earnings results on Wednesday, August 7th. The company reported $7.88 earnings per share for the quarter, beating analysts’ consensus estimates of $7.21 by $0.67. The business had revenue of $79.28 billion during the quarter, compared to the consensus estimate of $82.53 billion. McKesson had a net margin of 0.94% and a negative return on equity of 242.57%. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $7.27 EPS. As a group, analysts forecast that McKesson Co. will post 32.11 earnings per share for the current fiscal year.
McKesson Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 1st. Investors of record on Monday, September 2nd will be issued a $0.71 dividend. This is a positive change from McKesson’s previous quarterly dividend of $0.62. The ex-dividend date of this dividend is Friday, August 30th. This represents a $2.84 annualized dividend and a yield of 0.55%. McKesson’s payout ratio is presently 12.69%.
Insider Buying and Selling at McKesson
In other news, CEO Brian S. Tyler sold 3,753 shares of McKesson stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $626.03, for a total value of $2,349,490.59. Following the completion of the transaction, the chief executive officer now directly owns 82,339 shares of the company’s stock, valued at approximately $51,546,684.17. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Over the last quarter, insiders have sold 11,259 shares of company stock valued at $6,635,492. 0.11% of the stock is currently owned by insiders.
McKesson Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Read More
- Five stocks we like better than McKesson
- Insider Trades May Not Tell You What You Think
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Overbought Stocks Explained: Should You Trade Them?
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- EV Stocks and How to Profit from Them
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.